Ameriprise
ETRM

Ameriprise’s EnteroMedics Inc. ETRM Stock Holding History

Ameriprise’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1
Closed -$2K – 5538
2014
Q3 		$2K Hold
1
– – ﹤0.01% 5501
2014
Q2 		$2K Hold
1
– – ﹤0.01% 5286
2014
Q1 		$2K Hold
1
– – ﹤0.01% 5119
2013
Q4 		$3K Hold
1
– – ﹤0.01% 4833
2013
Q3 		$2K Hold
1
– – ﹤0.01% 5451
2013
Q2 		$1K Buy
+1
New +$1.06K ﹤0.01% 5482

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Ameriprise's ETRM Position: Q4 2014 in Review

Ameriprise sold out of EnteroMedics Inc. (ETRM) in Q4 2014, closing a stake of 1 share — an estimated $2K sold.

Ameriprise first reported a position in ETRM in Q2 2013 and held it in 6 quarters. The position peaked at $3K in Q4 2013. 46 funds tracked by Wall St. Rank hold ETRM as of Q4 2014.

  • Ameriprise reported no remaining EnteroMedics Inc. position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 1 EnteroMedics Inc. share in Q4 2014, an estimated $2K.
  • Ameriprise first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 6 quarters.
  • Ameriprise's EnteroMedics Inc. position peaked at $3K in Q4 2013.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.